Form D · Biotechnology

APOLLO ENDOSURGERY US INC

Austin, TX · CIK 0001369432

Offering snapshot reported Jan 11, 2017 · SEC filing

Reported sold
$54.4M
Offering amount: $54.4M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 29, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 11, 2017Initial$54,432,580No comparison15SEC filing
Dec 16, 2013Initial$60,727,392No comparison11SEC filing
Jul 3, 2013Initial$5,044,998No comparison8SEC filing
Feb 10, 2012Initial$52,724,242No comparison14SEC filing
Mar 23, 2009Initial$3,000,000No comparisonNot reportedSEC filing
Oct 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Dec 15, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jun 20, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-278165
Common Stock

Source: Form D, filed Jan 11, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rick Anderson Director
Stefanie Cavanaugh Executive
Matthew Crawford Director
John Creecy Director
Michael J Doty Executive
William Mc Clellan, Jr. Director
R. Kent Mc Gaughy, Jr. Director
Dennis Mc Williams Executive
Richard Meelia Director
Todd Newton Director, Executive
Jack Nielsen Director
Bruce Robertson Director
Bruce Robertson, Ph.D. Director
Bret Schwartzhoff Executive
Charles Tribie Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1120 South Capital Of Tx Hwy Building 1 Suite 300
Austin, TX, 78746